c-Rel/NN
is/VBZ
a/DT
target/NN
of/IN
pentoxifylline-mediated/JJ
inhibition/NN
of/IN
T/NN
lymphocyte/NN
activation/NN
./.

The/DT
possible/JJ
clinical/JJ
use/NN
of/IN
the/DT
methyl/NN
xanthine/NN
derivative/JJ
,/,
pentoxifylline/NN
(/(
PF/NN
)/)
,/,
for/IN
the/DT
treatment/NN
of/IN
T/NN
cell-dependent/JJ
diseases/NNS
is/VBZ
being/VBG
noted/VBN
with/IN
increasing/VBG
interest/NN
./.
=====
In/IN
this/DT
paper/NN
,/,
we/PRP
studied/VBD
the/DT
molecular/JJ
consequences/NNS
of/IN
PF/NN
treatment/NN
during/IN
lymphocyte/NN
activation/NN
./.
=====
We/PRP
found/VBD
that/IN
in/IN
T/NN
cells/NNS
,/,
anti-CD3-induced/JJ
c-Rel/NN
expression/NN
was/VBD
blocked/VBN
by/IN
PF/NN
,/,
whereas/IN
the/DT
induction/NN
of/IN
other/JJ
NF-kappaB/NN
family/NN
members/NNS
was/VBD
not/RB
significantly/RB
affected/VBN
./.
=====
However/RB
,/,
induction/NN
of/IN
NF-AT/NN
,/,
which/WDT
has/VBZ
the/DT
same/JJ
signaling/NN
requirements/NNS
as/IN
c-Rel/NN
induction/NN
,/,
was/VBD
not/RB
inhibited/VBN
by/IN
PF/NN
./.
=====
Among/IN
genes/NNS
that/WDT
respond/VBP
to/TO
these/DT
transcription/NN
factors/NNS
,/,
IL-2/NN
mRNA/NN
induction/NN
was/VBD
suppressed/VBN
by/IN
PF/NN
,/,
whereas/IN
IL-2R/NN
(/(
alpha/NN
)/)
chain/NN
mRNA/NN
induction/NN
was/VBD
not/RB
affected/VBN
./.
=====
These/DT
observations/NNS
implicated/VBD
c-Rel/NN
as/IN
an/DT
IL-2/NN
promoter/NN
factor/IN
,/,
for/IN
which/WDT
experimental/JJ
support/NN
was/VBD
obtained/VBN
from/IN
transient/JJ
transfection/NN
experiments/NNS
./.
=====
In/IN
contrast/NN
with/IN
the/DT
observation/NN
in/IN
T/NN
cells/NNS
,/,
c-Rel/NN
induction/NN
was/VBD
not/RB
blocked/VBN
by/IN
PF/NN
in/IN
B/NN
cells/NNS
./.
=====
The/DT
greater/JJR
selectivity/NN
of/IN
PF/NN
,/,
compared/VBN
with/IN
FK506/NN
,/,
at/IN
both/CC
the/DT
molecular/JJ
and/CC
cellular/JJ
levels/NNS
may/MD
prove/VB
advantageous/JJ
in/IN
manipulating/VBG
T/NN
cell/NN
responses/NNS
in/FW
vivo/FW
./.